PRESS RELEASE published on 11/20/2025 at 15:46, 11 months 19 days ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group discloses a 5.71% stake in Avadel Pharmaceuticals plc. Form 8.3 submitted to the Irish Takeover Panel on 20-Nov-2025 Form 8.3 Irish Takeover Panel Vanguard Group Stake Disclosure Avadel Pharmaceuticals Plc
BRIEF published on 11/20/2025 at 15:46, 11 months 19 days ago The Vanguard Group Discloses Interests in Spire Healthcare Form 8.3 Takeover Code Spire Healthcare Shareholding Vanguard
PRESS RELEASE published on 11/20/2025 at 15:45, 11 months 19 days ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses a 1.67% interest in Mural Oncology plc as per Form 8.3 to the Irish Takeover Panel Form 8.3 Irish Takeover Panel Vanguard Group Interest Disclosure Mural Oncology Plc
BRIEF published on 11/20/2025 at 15:45, 11 months 19 days ago The Vanguard Group Discloses Position in Dowlais Group plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group Dowlais Group Plc
BRIEF published on 11/20/2025 at 15:44, 11 months 19 days ago The Vanguard Group Discloses Stake in Empiric Student Property Securities Takeover Code Vanguard Group Stake Disclosure Empiric Student Property
PRESS RELEASE published on 11/20/2025 at 15:44, 11 months 19 days ago Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc The Vanguard Group, Inc. discloses 5.33% stake in Greencore Group plc. Additional disclosure for Bakkavor Group plc. Purchase and sale details included Vanguard Group Stake Disclosure Purchase And Sale Greencore Group Plc Bakkavor Group Plc
PRESS RELEASE published on 11/20/2025 at 15:43, 11 months 19 days ago Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited The Vanguard Group, Inc. discloses owning 1.23% of Bluefield Solar Income Fund Limited's ordinary securities as of 19 Nov 2025 Securities Vanguard Group Ownership Disclosure Financial Disclosure Bluefield Solar Income Fund
BRIEF published on 11/20/2025 at 15:42, 11 months 19 days ago Vanguard Group Discloses Stake in Petershill Partners Takeover Code Securities Disclosure Vanguard Group Shareholding Petershill Partners
PRESS RELEASE published on 11/20/2025 at 15:41, 11 months 19 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses a 3.57% interest in Spire Healthcare Group plc per Form 8.3. Details of securities dealt & positions held disclosed Securities The Vanguard Group, Inc. Form 8.3 Positions Spire Healthcare Group Plc
BRIEF published on 11/20/2025 at 15:40, 11 months 19 days ago The Vanguard Group Discloses Position in Bakkavor Group plc Disclosure Takeover Code Vanguard Group Shareholding Bakkavor Group
Published on 11/10/2026 at 11:00, 26 minutes ago 3D Induced Polarization Survey Identifies a Large Drill Target at East Goldfield
Published on 11/10/2026 at 08:00, 3 hours 26 minutes ago PEL 82 - QatarEnergy to Acquire 25% Participating Interest from Chevron
Published on 11/10/2026 at 02:45, 8 hours 41 minutes ago Presentation to Zurich Precious Metals Summit
Published on 11/09/2026 at 23:10, 12 hours 16 minutes ago Ur-Energy Reports Third Quarter 2026 Results
Published on 11/09/2026 at 23:00, 12 hours 26 minutes ago LNG Energy Group Announces Issuance of Third Partial Revocation Order and Proposed Shares-for-Debt Settlement
Published on 11/10/2026 at 11:16, 10 minutes ago Second drill rig mobilised as Lionheart construction ramps up
Published on 11/10/2026 at 11:04, 22 minutes ago aap increases revenue by 2% in the third quarter of 2026 – on top of the already high prior-year level
Published on 11/10/2026 at 10:50, 36 minutes ago German R&D Tax Credits: New Administrative Instruction by Federal Ministry of Finance Tightens Documentation Requirements
Published on 11/10/2026 at 10:09, 1 hour 17 minutes ago EQS-Adhoc: Emerald Horizon AG plans to raise approximately EUR 135 million in equity by 2028 and resolves first cash capital increase
Published on 11/10/2026 at 11:02, 24 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of October 31, 2026
Published on 11/10/2026 at 07:00, 4 hours 26 minutes ago bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/09/2026 at 18:30, 16 hours 56 minutes ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
Published on 11/09/2026 at 17:35, 17 hours 51 minutes ago Disclosure of transactions in own shares from November 2 to November 6, 2026
